TB500 20MG (Thyomosin Beta 4) – 20MG per vial

Clinical Test Expectation TB500 20MG- Human Subjects : Formation of new blood vessels leading to anti-inflammation and wound healing. Hair growth Strength - 20MG per vial

Introduction TB500 20MG is a synthetic peptide version of the naturally occurring healing protein present in about all human and mammalian cells known as Thymosin Beta 4 (TB4). Research has shown TB 500 to have beneficial effects on wound healing, injury recovery, flexibility, and inflammation. These desirable effects are accomplished through TB 500’s influence on blood cell and blood vessel development, cellular differentiation, and cell migration. A major part of its healing capability stems from the peptide’s regulation of actin, a cell building protein essential to healing and wound repair.

TB500 20MG research illustrates multiple properties that have provided the impetus for a worldwide series of clinical trials of potential effectiveness for thymosin beta-4 in promoting repair of wounds in skin, cornea and heart. Thymosin beta 4 is produced in the thymus gland and is found in high concentrations in wound fluids. As such it has been observed to facilitate healing of injured tissue in the body.

TB500 20MG is a naturally occurring peptide found in high concentrations in blood platelets, wound fluid and other tissues. TB-500 peptides for research are not growth factors; rather major actin regulating protein peptides. TB 500 has been found to play an important role in protection, regeneration and remodeling of injured and/or damaged tissues. The gene for Thymosin Beta-4 has also been found to be one of the first to be stimulated after an incident of injury.

Present in almost all human and animal cells, Thymosin Beta 4 is naturally occurring wound healing peptide. TB 500 is a synthetically made version of TB4 that facilitates healing and recovery by helping build new blood vessels, muscle tissue fibers, blood cells, and facilitating cell migration. For the overworked or injured individual, TB 500 offers extremely enticing wound healing effects.

TB 500 is able to help recovery by exerting effects on actin. By up-regulating this cellular protein, TB 500 is able to capitalize on actin’s positive effects. These include the promotion of cell migration and proliferation. As a result, new blood vessels form and inflammation can be regulated so that healing and recovery are optimized. In addition, TB 500’s unique molecular structure allows it to travel long distances in the body. This enables it to exert a “systemic” effect, seeking out and helping those areas of the body suffering injury. Further beneficial results of TB 500 administration can include reduced inflammation and enhanced flexibility. There have even been some reports of regrowing and darkening of hair.

Dosing Details You inject 2ml water into the vial of TB500 from the water vial. 1 full syringe is 1ml. You then wait for the vial powder content to dissolve ON ITS OWN. DO NOT SHAKE THE VIAL TO MIX POWDER. Once dissolved and clear in colour you draw out 50 (5 units) on syringe and inject it into the tummy under the skin into the fatty skin layer. This will give you a 5MG dose of TB500 used once a week.

There are also several other dosing protocols available online for this item. We only suggest usage as above however this product is safe to dose in most ways without danger.

How long will a vial last ? A vial should last 30 days.

Clinical Test Expectation LL-37 - Human Subjects : Antibiotic resistant infections. Immune system booster. Staphylococcus Aureus bacteria barrier. Beneficial for those who suffer with autoimmune disease, Inflammatory Bowel Disease, arthritis or Lupus. Strength - 5MG per vial

Introduction LL-37 is an antimicrobial peptide (AMP) that belongs to the cathelicidin family and serves as an alternative to antibiotics. An AMP can eliminate the bugs, regulate bacterial invasions, and control infections and inflammation. The peptide is naturally produced within the body through various tissues and circulates throughout different cells including bone marrow cells, epithelial cells and gastrointestinal tract cells. However, if the body doesn’t produce enough, it becomes vulnerable to bad bacteria, eventually causing it to accumulate pathogens and create chronic diseases and inflammation. Peptides contain amino acids that release certain proteins to focus on refining certain bodily functions. LL-37 contains approximately 12-80 amino acids with the purpose of assisting patients build immunity and fight contagious viruses.

Peptide LL-37 acts as the first line of defense when the body is suffering from injuries, infections, wounds or inflammation. Because of this, the peptide is useful in treating those suffering from tick-borne illnesses such as Lyme, RMSF, Anaplasmosis, Babesiosis and Colorado Tick Fever. Other research has shown that the peptide is effective in treating conditions such as diabetes, E. Coli, Candida Albicans, and certain types of cancer. While it’s mostly known for its anti-biofilm, the peptide also plays a critical role in regulating inflammatory molecules and contains healing properties to damaged tissues. This is especially beneficial for those who suffer with autoimmune disease, Inflammatory Bowel Disease, arthritis or Lupus.

Dosing Details You inject 2ml water into the vial of LL-37 from the water vial. 1 full syringe is 1ml. You then wait for the vial powder content to dissolve ON ITS OWN. DO NOT SHAKE THE VIAL TO MIX POWDER. Once dissolved and clear in colour you draw out 30 (3 units) on the syringe each night before bed and inject it into the tummy under the skin into the fatty skin layer.

How long will a vial last ? A vial should last 7 days.

Clinical Test Expectation - Tirzepatide - Human Subjects : Aids type 2 diabetis. Assist with large scale weight loss. Strength - 2MG per vial

Introduction Historically, the treatment of obesity focused almost exclusively on lifestyle-based approaches. However, evidence that diet and exercise prompt physiological counterregulatory mechanisms that limit weight reduction and impede weight maintenance has led to the realization that obesity is a complex, multicomponent metabolic disease of energy homeostasis involving central and peripheral mechanisms. Once obesity is present, those mechanisms render a return to lower weight difficult. Accordingly, several clinical guidelines now recommend treatment with antiobesity medications for people with obesity or for those with overweight and weight-related complications. Recent studies with long-acting glucagon-like peptide-1 (GLP-1) receptor agonists demonstrated that greater efficacy with acceptable safety could be achieved by targeting the pathways of endogenous nutrient-stimulated hormones. Glucose-dependent insulinotropic polypeptide (GIP), another nutrient-stimulated hormone, regulates energy balance through cell-surface receptor signaling in the brain and adipose tissue. A molecule that combines both GIP and GLP receptor agonism theoretically may lead to greater efficacy in weight reduction.

Tirzepatide is a once-weekly subcutaneous injectable peptide (approved by the Food and Drug Administration [FDA] for type 2 diabetes) engineered from the native GIP sequence, with agonist activity at both the GIP and GLP-1 receptors. Preclinical data demonstrated that the affinity of tirzepatide for GIP receptors was equal to the affinity of native GIP for GIP receptors, whereas tirzepatide bound GLP-1 receptors with affinity approximately five times weaker than native GLP-1 bound GLP-1 receptors. GIP activation appeared to act synergistically with GLP-1 receptor activation to allow greater weight reduction in humans than that achieved with GLP-1 receptor monoagonism. In phase 2 studies in people with type 2 diabetes, tirzepatide induced clinically relevant weight reduction, warranting further investigation for the treatment of obesity. The present trial, SURMOUNT-1, evaluated the efficacy and safety of tirzepatide in adults with obesity or overweight who did not have diabetes with great success

Dosing Details You inject 1ml water into the vial of Tirzepatide from the water vial. 1 full syringe is 1ml. You then wait for the vial powder content to dissolve ON ITS OWN. DO NOT SHAKE THE VIAL TO MIX POWDER. Once dissolved and clear in colour you draw out the entire vial and inject it into the tummy under the skin into the fatty skin layer. A vial should last 1 usage once a week.

How long will a vial last ? A vial should last 7 days.

Clinical Test Expectation ACE-031 - Human Subjects : Massive increases in muscle mass and strength Strength - 1MG per vial

Introduction ACE-031 is a soluble form of activin receptor type IIB (ActRIIB). ACE-031 promotes muscle growth by binding to myostatin and other negative regulators of muscle mass.

The scientists are still figuring out what properties the peptide has , but we already know a number of beneficial effects of its use, including:

• acceleration of muscle gain process by blocking myostatin hormone;
• fat-burning effect. ACE-031 reduces the amount of leptin and thus increases the adiponectin level;
• improves the density of bones, thus making them more durable and less prone to fractures and other injuries;
• no side effects. The peptide is absolutely safe, when administered at dosages that do not exceed the norm, ACE-031 does not have any side effects. Very rarely there may be headaches and discomfort at the injection site.

Dosing Details You inject 1.1ml water into the vial of ACE031 from the water vial. 1 full syringe is 1ml. You then wait for the vial powder content to dissolve ON ITS OWN. DO NOT SHAKE THE VIAL TO MIX POWDER. Once dissolved and clear in colour you draw out 5 (half a unit) on the syringe each day in the morning and inject it into the muscle (Intra Muscular) at site of growth bilaterally (that is 2.5 into each side totaling 5) directly into muscle. Alternative for easier use :You inject 2.1ml water into the vial of ACE031 from the water vial. 1 full syringe is 1ml. You then wait for the vial powder content to dissolve ON ITS OWN. DO NOT SHAKE THE VIAL TO MIX POWDER. Once dissolved and clear in colour you draw out 10 (1 unit) on the syringe each day in the morning and inject it into the muscle (Intra Muscular) at site of growth bilaterally (that is 5 into each side totaling 10) Directly into muscle.

How long will a vial last ? A vial should last 10 days.

Clinical Test Expectation - Human Subjects : Lower blood sugar levels, enhance insulin secretion, improve heart, liver, and lung function while helping to slow or prevent the effects of Alzheimer’s disease. Decrease appetite by delaying gastric emptying and reducing intestinal motility. Reduce weight gain Strength - 3MG per vial

Introduction Along with helping to control blood sugar and boost weight loss, GLP-1s and SGLT-2 inhibitors seem to have other major benefits. Research has found that some drugs in these groups may lower the risk of heart disease, such as heart failure, stroke and kidney disease.

There's a class of type 2 diabetes drugs that not only improves blood sugar control but is best for weight loss. This class of drugs is commonly called glucagon-like peptide 1 (GLP-1) agonists (semaglutide). A second class of drugs that may lead to weight loss and improved blood sugar control is the sodium glucose cotransporter 2 (SGLT-2) inhibitors. These include canagliflozin (Invokana), ertugliflozin (Steglatro), dapagliflozin (Farxiga) and empagliflozin (Jardiance).

Weight loss can vary depending on which GLP-1 drug you use and your dose. Studies have found that all GLP-1 drugs can lead to weight loss of about 4.8 to 7.2 kilograms, when using liraglutide. Studies found people using semaglutide and making lifestyle changes lost about 15.3 kilograms versus 2.6 kilograms in those who didn't use the drug.

Diabetes drugs in the GLP-1 agonists class are generally taken by a shot (injection) given daily or weekly and include:

• Dulaglutide (Trulicity) (weekly)
• Exenatide extended release (Bydureon bcise) (weekly)
• Exenatide (Byetta) (twice daily)
• Semaglutide (GLP-1/Ozempic) (weekly)
• Liraglutide (Victoza, Saxenda) (daily)
• Lixisenatide (Adlyxin) (daily)
• Semaglutide (Rybelsus) (taken by mouth once daily)

These drugs mimic the action of a hormone called glucagon-like peptide 1. When blood sugar levels start to rise after someone eats, these drugs stimulate the body to produce more insulin. The extra insulin helps lower blood sugar levels.

Lower blood sugar levels are helpful for controlling type 2 diabetes. But it's not clear how the GLP-1 drugs lead to weight loss. Doctors do know that GLP-1s appear to help curb hunger. These drugs also slow the movement of food from the stomach into the small intestine. As a result, you may feel full faster and longer, so you eat less.

Along with helping to control blood sugar and boost weight loss, GLP-1s and SGLT-2 inhibitors seem to have other major benefits. Research has found that some drugs in these groups may lower the risk of heart disease, such as heart failure, stroke and kidney disease. People taking these drugs have seen their blood pressure and cholesterol levels improve. But it's not clear whether these benefits are from the drug or the weight loss.

The downside to GLP-1 drugs is that all but one has to be taken by a shot. And, like any drug, there is a risk of side effects, some serious. More common side effects often improve as you continue to take the drug for a while.

Some of the more common side effects include:

• Nausea
• Vomiting
• Diarrhea

Low blood sugar levels (hypoglycemia) are a more serious risk linked to the GLP-1 class of drugs. But the risk of low blood sugar levels often only goes up if you're also taking another drug known to lower blood sugar at the same time, such as sulfonylureas or insulin.

The GLP-1 class of drugs isn't recommended if you have a personal or family history of medullary thyroid cancer or multiple endocrine neoplasia. Lab studies have linked these drugs with thyroid tumors in rats. But until more long-term studies are done, the risk to humans isn't known. They're also not recommended if you've had pancreatitis.

Dosing Details STARTING DOSE : You inject 3ml water into the vial of GLP-1 from the water vial. 1 full syringe is 1ml. You then wait for the vial powder content to dissolve ON ITS OWN. DO NOT SHAKE THE VIAL TO MIX POWDER. Once dissolved and clear in colour you draw out 0.75 (3 quarters of syringe) once a week in the morning before breakfast and inject it into the tummy under the skin into the fatty skin layer. A vial should last 4 weeks.

MAINTENANCE DOSE :You inject 1ml water into the vial of GLP-1 from the water vial. 1 full syringe is 1ml. You then wait for the vial powder content to dissolve ON ITS OWN. DO NOT SHAKE THE VIAL TO MIX POWDER. Once dissolved and clear in colour you draw out the entire vial once a week in the morning before breakfast and inject it into the tummy under the skin into the fatty skin layer. A vial should last 1 week.

How long will a vial last ? A vial should last 4 weeks on start A vial should last 1 week on maintenance

Clinical Test Expectation - Human Subjects : Super fast joint, tendon, ligament healing. Heal wounds in internal organs, muscles, ligaments, tendons, skin, internal lacerations from surgery Strength - 5MG per vial

Introduction BPC 157, a pentadecapeptide derived from human gastric juice, has been demonstrated to promote the healing of different tissues, including skin, muscle, bone, ligament and tendon in many animal studies. Stable gastric pentadecapeptide BPC-157 is is a synthetic peptide chain. A peptide is simply a sequence of amino acids. BCP specifically is composed of 15 amino acids derived from a protective protein found in the stomach. BPC, short for 'body protective compound', is already found in human gastric juices in small amounts to heal the gut, but can be taken supplementally to benefit anywhere in the body. BPC-157 is a cytoprotective compound, meaning its actions include aiding the healing process including remodeling and protective effects. It can also protect against oxidative stress.

Dosing Details You inject 2ml water into the vial of BPC 157 from the water vial. 1 full syringe is 1ml. You then wait for the vial powder content to dissolve ON ITS OWN. DO NOT SHAKE THE VIAL TO MIX POWDER. Once dissolved and clear in colour you draw out 25 – 30 (two and a half to 3 units) on the syringe each morning before breakfast and inject it into the tummy under the skin into the fatty skin layer.

How long will a vial last ? A vial should last 7-8 days.